Iaculor Injection Overview
- Founded
- 2006
- Status
- Private
- Latest Deal Type
- 2ndary - Private
Iaculor Injection General Information
Description
Developer of medical devices designed to offer delivery of vaccines in either liquid or powder form. The company's devices are precise, effective, safe, low-cost and simple to use, enabling healthcare providers to get needle-free medical devices for drug delivery and improve the lives of the patients.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Medical Supplies
Primary Office
- 3201 Jean-Migneault Street
- Fleurimont
- Sherbrooke, Quebec J1H 5H3
- Canada
Iaculor Injection Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Mar-2021 | Completed | Startup | |||
| 1. Seed Round | 28-Jun-2006 | Completed | Startup |
Iaculor Injection Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jean Gosselin | Co-Founder, Chief Executive Officer & President | ||
| Martin Brouillette | Co-Founder |